KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Elanco Animal Health (ELAN) EBT (2017 - 2026)

Elanco Animal Health's EBT history spans 9 years, with the latest figure at -$259.0 million for Q4 2025.

  • On a quarterly basis, EBT fell 407.84% to -$259.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$224.0 million, a 145.9% decrease, with the full-year FY2025 number at -$224.0 million, down 145.9% from a year prior.
  • EBT hit -$259.0 million in Q4 2025 for Elanco Animal Health, down from -$50.0 million in the prior quarter.
  • Over the last five years, EBT for ELAN hit a ceiling of $559.0 million in Q3 2024 and a floor of -$1.1 billion in Q3 2023.
  • Historically, EBT has averaged -$78.6 million across 5 years, with a median of -$50.5 million in 2024.
  • Biggest five-year swings in EBT: plummeted 2393.18% in 2023 and later surged 400.0% in 2025.
  • Tracing ELAN's EBT over 5 years: stood at -$120.0 million in 2021, then rose by 25.83% to -$89.0 million in 2022, then crashed by 42.7% to -$127.0 million in 2023, then skyrocketed by 59.84% to -$51.0 million in 2024, then crashed by 407.84% to -$259.0 million in 2025.
  • Business Quant data shows EBT for ELAN at -$259.0 million in Q4 2025, -$50.0 million in Q3 2025, and $25.0 million in Q2 2025.